» Articles » PMID: 28778558

Management of Cancer Cachexia and Guidelines Implementation in a Comprehensive Cancer Center: A Physician-Led Cancer Nutrition Program Adapted to the Practices of a Country

Abstract

Context: Cancer-associated cachexia is correlated with survival, side-effects, and alteration of the patients' well-being.

Objectives: We implemented an institution-wide multidisciplinary supportive care team, a Cancer Nutrition Program (CNP), to screen and manage cachexia in accordance with the guidelines and evaluated the impact of this new organization on nutritional care and funding.

Methods: We estimated the workload associated with nutrition assessment and cachexia-related interventions and audited our clinical practice. We then planned, implemented, and evaluated the CNP, focusing on cachexia.

Results: The audit showed a 70% prevalence of unscreened cachexia. Parenteral nutrition was prescribed to patients who did not meet the guideline criteria in 65% cases. From January 2009 to December 2011, the CNP team screened 3078 inpatients. The screened/total inpatient visits ratio was 87%, 80%, and 77% in 2009, 2010, and 2011, respectively. Cachexia was reported in 74.5% (n = 2253) patients, of which 94.4% (n = 1891) required dietary counseling. Over three years, the number of patients with artificial nutrition significantly decreased by 57.3% (P < 0.001), and the qualitative inpatients enteral/parenteral ratio significantly increased: 0.41 in 2009, 0.74 in 2010, and 1.52 in 2011. Between 2009 and 2011, the CNP costs decreased significantly for inpatients nutritional care from 528,895€ to 242,272€, thus financing the nutritional team (182,520€ per year).

Conclusion: Our results highlight the great benefits of implementing nutritional guidelines through a physician-led multidisciplinary team in charge of nutritional care in a comprehensive cancer center.

Citing Articles

Exosomes in the pathogenesis and treatment of cancer-related cachexia.

Ru Q, Chen L, Xu G, Wu Y J Transl Med. 2024; 22(1):408.

PMID: 38689293 PMC: 11062016. DOI: 10.1186/s12967-024-05201-y.


Holistic multimodal care for patients with cancer cachexia and their family caregivers.

Amano K, Hopkinson J, Baracos V, Mori N Asia Pac J Oncol Nurs. 2024; 10(Suppl 1):100290.

PMID: 38197043 PMC: 10772164. DOI: 10.1016/j.apjon.2023.100290.


Identification of F-FDG PET/CT Parameters Associated with Weight Loss in Patients with Esophageal Cancer.

Galvez T, Berkane I, Thezenas S, Eberle M, Flori N, Guillemard S Nutrients. 2023; 15(13).

PMID: 37447367 PMC: 10346913. DOI: 10.3390/nu15133042.


Factors affecting the assessment of cancer cachexia by nurses caring for patients with advanced cancer undergoing chemotherapy: A cross-sectional survey.

Sato R, Hayashi N, Nakayama N, Okimura A Asia Pac J Oncol Nurs. 2022; 9(9):100075.

PMID: 35669286 PMC: 9163426. DOI: 10.1016/j.apjon.2022.100075.


Cancer cachexia syndrome: Reflecting on 20 years of providing cancer cachexia care as the leader of an interdisciplinary team in an Australian cancer center.

Martin P Asia Pac J Oncol Nurs. 2022; 9(9):100070.

PMID: 35637652 PMC: 9142557. DOI: 10.1016/j.apjon.2022.04.009.